Teva Pharmaceutical Industries announced that Shlomo Yanai, president and CEO, will retire from his post in May.
Mylan has launched a generic drug for treating high blood pressure, the company said.
The Food and Drug Administration has approved a drug for epilepsy made by Mylan, the drug maker said.
Actavis has begun shipping clobetasol propionate shampoo and clobetasol propionate lotion, which were granted 180-day marketing exclusivity by the Food and Drug Administration.
Baxter and Momenta have agreed to partner to develop and market biosimilar drugs to treat cancer, autoimmune disorders and other chronic conditions.
Drug makers will focus on patient-specific therapies instead of drugs designed for use by a broad range of people over the next decade, according to a new report released Thursday by Thomson Reuters.
Drug maker Actavis is partnering with QRxPharma to sell what the former called a novel pain drug in the United States.
Amneal Pharmaceuticals has launched its generic version of a drug designed to treat seizures in adults and children with epilepsy.
Ranbaxy Labs said Wednesday that it had resolved long-standing issues concerning two of its manufacturing plants in India with the U.S. government.
Upsher-Smith has launched an online portal for advanced-practice clinicians interested in women's health, the company said.